# ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Study · id `cardio:ct-nct03507777` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03507777](<https://clinicaltrials.gov/study/NCT03507777>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03507777

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2487 participants.

## Technical summary

Registry record NCT03507777. Randomized; double masking; primary purpose treatment. Start 2018-05-17 (actual); primary completion 2023-02-28 (actual). Results posted on 2024-08-01.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2487 participants (enrolled count; ClinicalTrials.gov record NCT03507777, source copy `cardio:ctgov-nct03507777-2024-08-01`, retrieved 2026-10-26)
- Started: 2018-05-17 (actual) (ClinicalTrials.gov record NCT03507777, source copy `cardio:ctgov-nct03507777-2024-08-01`, retrieved 2026-10-26)
- Primary completion: 2023-02-28 (actual) (ClinicalTrials.gov record NCT03507777, source copy `cardio:ctgov-nct03507777-2024-08-01`, retrieved 2026-10-26)
- Completion: 2023-02-28 (actual) (ClinicalTrials.gov record NCT03507777, source copy `cardio:ctgov-nct03507777-2024-08-01`, retrieved 2026-10-26)
- Results first posted: 2024-08-01 (ClinicalTrials.gov record NCT03507777, source copy `cardio:ctgov-nct03507777-2024-08-01`, retrieved 2026-10-26)
- Countries: United States; Australia; Belgium; Canada; Denmark; France; Germany; Hong Kong SAR China; India; Italy; Japan; Netherlands; New Zealand; Portugal; Singapore; Spain; Sweden; Switzerland; Taiwan; United Kingdom (ClinicalTrials.gov record NCT03507777, source copy `cardio:ctgov-nct03507777-2024-08-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03507777-2024-08-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)
- Condition: Coronary Artery Disease
- Condition: Coronary Stenosis
- Condition: Atherosclerosis
- Condition: STEMI
- Condition: STEMI - ST Elevation Myocardial Infarction
- Condition: NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Intervention (Device): Coronary PCI guided by OCT
- Intervention (Device): Coronary PCI guided by Angiography
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Optical Coherence Tomography-Guided versus Angiography-Guided PCI (`cardio:pubmed-37634188`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: OCT-Guided vs Angiography-Guided Coronary Stent Implantation in Complex Lesions: An ILUMIEN IV Substudy (`cardio:pubmed-38759907`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and Efficacy of Cobalt Chromium Everolimus-Eluting Stents for Treatment of In-Stent Restenosis: An ILUMIEN IV Substudy (`cardio:pubmed-40401609`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Optical Coherence Tomography-Based Post-PCI Physiology Assessment to Predict Clinical Outcomes: An ILUMIEN-IV Substudy (`cardio:pubmed-40406943`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: OCT-Defined Plaque Morphology and Clinical Outcomes After Percutaneous Coronary Intervention: An ILUMIEN IV Substudy (`cardio:pubmed-42547197`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7540b24d6030dcbaf078e8ee240ae591eb8592b185c36eda96128ec1dc66ddaf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
